Selva Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Selva Therapeutics General Information

Description

Operator of a biotechnology company intended to develop therapeutics for treating certain viral and parasitic infectious diseases. The company offers a lead compound available as a small molecule novel antiviral therapy with activity against a broad range of viruses that threaten global health from binding to receptors needed for entry into human lung cells, enabling healthcare institutes to get a therapy against several viruses, either as a single oral agent or in combination with direct-acting antivirals.

Contact Information

Website
www.selvarx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2905 Hacienda Street
  • San Mateo, CA 94403
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2905 Hacienda Street
  • San Mateo, CA 94403
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Selva Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 15-Jan-2026 Completed Out of Business
3. Later Stage VC 01-Sep-2023 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 27-Oct-2020 $3M $3M Completed Startup
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Selva Therapeutics’s complete valuation and funding history, request access »

Selva Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Selva Therapeutics’s complete cap table history, request access »

Selva Therapeutics Patents

Selva Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026030705-A1 Combination therapeutics for antiviral treatment Pending 02-Aug-2024
US-20250195506-A1 Combination therapeutics for antiviral treatment Pending 14-Dec-2023
CA-3173931-A1 Viral entry inhibitors and rna polymerase inhibitors Pending 03-Apr-2020
EP-4125989-A1 Viral entry inhibitors and rna polymerase inhibitors Pending 03-Apr-2020
EP-4125989-A4 Viral entry inhibitors and rna polymerase inhibitors Pending 03-Apr-2020 A61K31/445
To view Selva Therapeutics’s complete patent history, request access »

Selva Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Selva Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of California, San Diego University
To view Selva Therapeutics’s complete investors history, request access »

Selva Therapeutics FAQs

  • When was Selva Therapeutics founded?

    Selva Therapeutics was founded in 2017.

  • Where is Selva Therapeutics headquartered?

    Selva Therapeutics is headquartered in San Mateo, CA.

  • What is the size of Selva Therapeutics?

    Selva Therapeutics has 4 total employees.

  • What industry is Selva Therapeutics in?

    Selva Therapeutics’s primary industry is Drug Discovery.

  • Is Selva Therapeutics a private or public company?

    Selva Therapeutics is a Private company.

  • What is Selva Therapeutics’s current revenue?

    The current revenue for Selva Therapeutics is .

  • How much funding has Selva Therapeutics raised over time?

    Selva Therapeutics has raised $3M.

  • Who are Selva Therapeutics’s investors?

    University of California, San Diego has invested in Selva Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process